Exploring the public’s perception and understanding of Parkinson’s disease in Ireland: a study protocol.

Publication date: Jul 02, 2025

There appears to be a lack of empirical investigation on how the public currently understands Parkinson’s Disease (PD)and the impact this has on people with PD and their carers, across Ireland. This research hopes to build a greater public understanding of PD, reduce stigma and improve the quality of life for people with PD. The aim of this study is to (1) explore public perceptions, awareness and understanding about PD across the island of Ireland and (2) discover how this impacts people with PD and their families. This study will adopt a mixed-methods, sequential explanatory methodology across four phases. This will include a systematic review of the literature, semi-structured interviews with people with PD and their carers, and focus groups with specialist PD professionals to determine how public perception impacts those living with PD. Following this, an online Delphi survey will be conducted with PD experts to determine a list of key priority areas for PD education. PD affects a large population of people worldwide and this number is expected to increase due to a progressively ageing population. There is a lack of empirical research exploring what the public know about PD and the impact this has on people living with the disease particularly in Ireland, therefore it is vital that we determine a list of priority areas for increasing PD awareness to improve the quality of life of those living with PD.

Open Access PDF

Concepts Keywords
Education Caregivers
Interviews Comprehension
Ireland Focus Groups
Large Humans
Parkinson Ireland
Lived Experiences
Parkinson Disease
Parkinson’s disease
Parkinson’s Stigma
Perception
Public Opinion
Quality of Life
Quality of Life
Stigma
Systematic review

Semantics

Type Source Name
disease MESH Parkinson’s disease
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH dementia
disease MESH anxiety
drug DRUGBANK Indoleacetic acid
disease MESH depression
drug DRUGBANK Polyethylene glycol
disease MESH Cervical Cancer
drug DRUGBANK Ademetionine
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Profenamine
drug DRUGBANK Methionine
pathway KEGG Parkinson disease
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Parkinsonism
disease MESH COVID 19 pandemic
disease MESH medication errors
drug DRUGBANK Isoxaflutole
disease MESH obesity
disease MESH Cognitive impairment

Original Article

(Visited 10 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *